Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Retained-Blood Outcomes With Active Clearance Technology. ACT Registry

NCT02145858 is registered in ClinicalTrials.gov with ClearFlow, Inc. as lead sponsor.

NCT NCT02145858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02145858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Retained-Blood Outcomes With Active Clearance Technology. ACT Registry
Lead sponsor
ClearFlow, Inc.
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
November 30, 2016
Enrollment
891 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, postoperative, hemorrhage